Enable Injections
Cincinnati, US · Founded 2010 · Delaware corporation · 225 employees on LinkedIn · 6 known investors
Find your way into Enable Injections
69 people in our graph share verified history with the Enable Injections team — schools, employers, funds. One of them is your warm intro.
Bob Stefanskiunlockedknows Mike Hooven · together at University of Michigan College of Engineering
×4knows the team · via University of Michigan College of Engineering
×7knows the team · via University of Michigan College of Literature, Science, and the Arts
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.
Founders & leadership
Enable Injections was founded in 2010 by Mike Hooven.
MH
Mike HooveninChairman, President and CEOHe holds over 30 years of medical device industry experience, including prior roles as Chairman and CEO of AtriCure (a publicly traded surgical device manufacturer he founded), founder and Chairman of Enable Medical (acquired by AtriCure in 2005), and head of product development at Ethicon Endo-Surgery. He earned a BS in Physics and MS in Mechanical Engineering from the University of Michigan.
TF
Timothy FlahertyExecutive
SS
Simone SongNamed on SEC filing
KR
Karen RobardsNamed on SEC filing
RJ
Richard J D'AugustineNamed on SEC filing
NR
Norman R. WeldonNamed on SEC filing
Board
Investors · 6
Reported raises · per SEC filings
Form D private placements$245M disclosed across 9 of 11 rounds · 2012–2025
▶$30MraisedJan 2026 · 1 investors · Other Health CareRule 506(b)
▶$30MraisedJan 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jim CollinsDirector
- Simone SongDirector
- Richard J. D'AugustineDirector
- John RiceDirector
- David KroekelExecutive Officer
- John DeFordDirector
- Matt HuddlestonExecutive Officer
- Timothy FlahertyExecutive Officer
- Beckie RobertsonDirector
- Michael D. HoovenExecutive Officer, Director
- Erik FalkDirector
- Nigel SheailDirector
- Vickie CappsDirector
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $1
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150MraisedFeb 2022 · 22 investors · Other Health CareRule 506(b)
▶$150MraisedFeb 2022 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John RiceDirector
- Timothy FlahertyExecutive Officer
- Michael D. HoovenExecutive Officer, Director
- Simone SongDirector
- Karen RobardsDirector
- Richard J D'AugustineDirector
- Norman R. WeldonDirector
- Offering amount
- $215M
- Amount sold
- $150M
- Minimum investment
- $1
- Sales commissions
- $8.3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.7MraisedOct 2018 · 15 investors · Other Health CareRule 506(b)
▶$30.7MraisedOct 2018 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard D'AugustineDirector
- Timothy FlahertyExecutive Officer
- Mark A. CollarDirector
- Michael D. HoovenExecutive Officer, Director
- Norman WeldonDirector
- John RiceDirector
- Daniel von AllmenDirector
- Simone SongDirector
- Susan SpiesExecutive Officer
- Offering amount
- $50M
- Amount sold
- $30.7M
- Minimum investment
- $1
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedNov 2016 · 1 investors · Other Health CareRule 506(b)
▶$25MraisedNov 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.9KraisedAug 2016 · 1 investors · Other Health Care
▶$22.9KraisedAug 2016 · 1 investors · Other Health Care
Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $22.9K
- Amount sold
- $22.9K
- First sale
- Jun 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 04
▶$2MraisedAug 2016 · 13 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2016 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Susan SpiesExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $25K
- First sale
- May 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5MraisedAug 2016 · 19 investors · Other Health CareRule 506(b)
▶$5MraisedAug 2016 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Susan SpiesExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jun 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$100KofferedAug 2016 · Other Health CareRule 506(b)
▶$100KofferedAug 2016 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $100K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Enable Injections do?
- Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.
- Who founded Enable Injections?
- Enable Injections was founded by Mike Hooven in 2010.
- Who are Enable Injections's investors?
- Enable Injections's investors include Angel Physicians Fund, CincyTech, Lightship Capital, Ohio Innovation Fund, Magnetar AI Ventures, Versant Ventures.
- How much funding has Enable Injections raised?
- Enable Injections has disclosed $245M raised across 9 of its 11 known rounds.
- Where is Enable Injections headquartered?
- Enable Injections is headquartered in Cincinnati, US.